SEC Form 4 · accession 0001209191-17-024286
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret Faye Wilson
Director
Period of report
Mar 31, 2017
Accepted (ET)
Apr 3, 2017 · 7:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.13 | Mar 31, 2017 | A | 4,166 | A | — | Mar 30, 2027 | Common Stock | 4,166 | 4,166 | D |
Explanation of responses
- F1The shares subject to the option shall be 100% vested and exercisable on June 28, 2017.